MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Depression and progression of motor symptoms in early stage of Parkinson’s disease

    YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association of depression with the progression of motor symptoms in patients with early-stage PD. Background: Depression is a major nonmotor symptom…
  • 2022 International Congress

    Psychometric characteristics of the Neuropsychiatric Fluctuation Scale

    E. Schmitt, B. Debu, A. Kistner, A. Castrioto, V. Fraix, M. Bouvard, E. Moro (grenoble, France)

    Objective: To evaluate the psychometric properties of the Neuropsychiatric fluctuation scale (NFS) for Parkinson’s disease (PD). Background: Neuropsychiatric fluctuations (NpsyF) in PD are frequent and…
  • 2022 International Congress

    Visual system abnormalities and visual hallucinations in Parkinson’s disease

    M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: We aimed to identify clinical and imaging biomarkers of visual system injury associated with the presence of Visual hallucinations (VH) in Parkinson's disease (PD).…
  • 2022 International Congress

    Priorities of PD patients for treatment of cognitive-driven ADL impairment

    I. Liepelt-Scarfone, M. Bentele, S. Becker, C. Altmann, E. Schaeffer, K. Michaelis, S. Solbrig, K. Brockmann (Tübingen, Germany)

    Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…
  • 2022 International Congress

    Blood-derived α-synuclein from Parkinson´s disease patients is able to seed pathology

    A. Kluge, J. Bunk, E. Schäffer, H. Knacke, A. Drobny, W. Xiang, R. Lucius, P. Arnold, F. Zunke, D. Berg (Kiel, Germany)

    Objective: To identify seeding capacities of soluble α-synuclein (α-syn) conformers derived from neuronal extracellular vesicles (NEs) from Parkinson´s disease (PD) patients. Background: PD pathology is…
  • 2022 International Congress

    Developing New Insights Into Clinical and Genetic Features of PD – The Global Parkinson’s Genetics Program (GP2) Clinical Cohorts Working Group

    M. Richer, C. Towns, A. Martinez-Carrasco, J. Solle, A. Singleton, C. Blauwendraat, M. Tan, H. Iwaki, D. Vitale, Y. Song, M. Nalls, T. Antar, H. Morris (London, United Kingdom)

    Objective: We aim to recruit Parkinson’s cohorts across the world for the Global Parkinson’s Genetics Program (GP2, http://gp2.org/), harmonize clinical data for joint analysis and…
  • 2022 International Congress

    Effect of wearing knee braces on unsteadiness on standing in a case with primary orthostatic tremor

    J. Tashiro, H. Ohtsuka, H. Fukaura, M. Hirotani, Y. Iida, T. Takahashi, S. Hamada, M. Nonaka, S. Honma, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

    Objective: To clarify the effect of wearing knee braces (KB) on unsteadiness on standing in a case with primary orthostatic tremor (OT) using stabilometry and…
  • 2022 International Congress

    Neurophysiological and Clinical Effects of Low-intensity Transcranial Ultrasound of the Motor Cortex in Parkinson’s Disease

    T. Grippe, Y. Shamli Oghli, G. Darmani, T. Arora, C. Sarica, C. Rinchon, J. Nankoo, C. Gunraj, R. Chen (Toronto, Canada)

    Objective: Evaluate the neurophysiological and clinical effects of transcranial ultrasound stimulation (TUS) of motor cortex (M1) in PD patients. Background: Low-intensity TUS is a novel,…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Qualification of Digital Endpoints of Function in Healthy Volunteers for Use in a Decentralized Natural History Study in Genetic Parkinson’s Disease (PD)

    S. Sankaranarayanan, C. Tomkins-Lane, D. Singamsetty, G. Yahalom, N. France, M. Maurer, C. Barlow (South San Francisco, USA)

    Objective: Our goal was to qualify digital and wearable devices to assess the Timed Up and Go (TUG) test and gait related parameters in healthy…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley